[Fulminant lobulated lung empyema caused by Pseudomonas aeruginosa]

Hsuan-Wei Chen1, Jing-Quan Zheng, Te-Yu Lin

  • 1Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.

Insights

A young man with diabetes developed severe meningoencephalitis and later Pseudomonas aeruginosa-induced lung empyema. This case highlights P. aeruginosa as a rare but critical cause of severe lung infections, especially in immunocompromised individuals.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • A 27-year-old male with diabetes mellitus presented with symptoms of meningoencephalitis following an upper respiratory tract infection.
  • Initial treatment included antibiotics and dexamethasone, with mechanical ventilation required for respiratory support.

Observation:

  • The patient developed severe pneumonia with rapidly progressing lung empyema and abscess formation.
  • Pleural fluid cultures identified Pseudomonas aeruginosa as the causative pathogen.

Findings:

  • Pseudomonas aeruginosa, typically causing bronchopneumonia, was found to be responsible for fulminant empyema and lung abscess in this case.
  • The patient's underlying diabetes mellitus and prior steroid therapy likely contributed to the severity and progression of the infection.

Implications:

  • This case underscores the importance of considering Pseudomonas aeruginosa in the differential diagnosis of severe, rapidly progressing lung empyema.
  • Immunocompromised patients, particularly those with diabetes or on steroid therapy, are at higher risk for unusual and severe presentations of P. aeruginosa infections.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...